- Uppsala, Sweden-based Orexo developed a low dose version of its opioid dependence treatment Zubsolv.
- The Mi-eye 2 is a second-generation diagnostic device used to diagnose and treat joint injuries.
- BurstDR is a physician-developed form of spinal cord stimulation used to treat patients with chronic pain.
- Jerusalem-based Teva Pharmaceutical Industries developed abacavir and lamivudine tablets to treat adults with HIV-1 infection.
More articles on supply chain:
FedEx to open new Ohio distribution center in 2017
Insmed buys AstraZeneca’s respiratory drug for $150M: 5 things to know
Novartis restructures research unit, sheds 175 jobs: 4 things to know
